MSpace at the University of Manitoba >
University of Manitoba Researchers (Research Publications) >
Research Publications >
Please use this identifier to cite or link to this item:
|Title: ||Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation|
|Authors: ||Schellenberg, Angela E|
Del Bigio, Marc R
|Issue Date: ||30-Apr-2012|
|Citation: ||Fluids and Barriers of the CNS. 2012 Apr 30;9(1):10|
The chemokine CCL2 has an important role in the recruitment of inflammatory cells into the central nervous system (CNS). A transgenic mouse model that overexpresses CCL2 in the CNS shows an accumulation of leukocytes within the perivascular space surrounding vessels, and which infiltrate into the brain parenchyma following the administration of pertussis toxin (PTx).
This study used contrast-enhanced magnetic resonance imaging (MRI) to quantify the extent of blood–brain barrier (BBB) disruption in this model pre- and post-PTx administration compared to wild-type mice. Contrast-enhanced MR images were obtained before and 1, 3, and 5 days after PTx injection in each animal. After the final imaging session fluorescent dextran tracers were administered intravenously to each mouse and brains were examined histologically for cellular infiltrates, BBB leakage and tight junction protein.
BBB breakdown, defined as a disruption of both the endothelium and glia limitans, was found only in CCL2 transgenic mice following PTx administration and seen on MR images as focal areas of contrast enhancement and histologically as dextrans leaking from blood vessels. No evidence of disruption in endothelial tight junctions was observed.
Genetic and environmental stimuli were needed to disrupt the integrity of the BBB in this model of neuroinflammation.|
|Type: ||Journal Article|
|Appears in Collections:||Research Publications|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.